000 | 01924 a2200517 4500 | ||
---|---|---|---|
005 | 20250515104402.0 | ||
264 | 0 | _c20080327 | |
008 | 200803s 0 0 eng d | ||
022 | _a1742-2094 | ||
024 | 7 |
_a10.1186/1742-2094-5-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXing, Bin | |
245 | 0 | 0 |
_aPioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. _h[electronic resource] |
260 |
_bJournal of neuroinflammation _cJan 2008 |
||
300 |
_a4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aEncephalitis _xdrug therapy |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aInflammation Mediators |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xdrug effects |
650 | 0 | 4 | _aLipopolysaccharides |
650 | 0 | 4 |
_aMicroglia _xdrug effects |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xdrug effects |
650 | 0 | 4 |
_aPPAR gamma _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xdrug effects |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xdrug effects |
700 | 1 | _aXin, Tao | |
700 | 1 | _aHunter, Randy Lee | |
700 | 1 | _aBing, Guoying | |
773 | 0 |
_tJournal of neuroinflammation _gvol. 5 _gp. 4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1742-2094-5-4 _zAvailable from publisher's website |
999 |
_c17713758 _d17713758 |